The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis.

 
Web www.patentalert.com

< Methods and uses of leukotriene B.sub.4 hydroxylases to treat diseases

> Keratinocyte derived interferon
~ 00417